Correlation between circulating stromal cell-derived factor 1 levels and CD4+ cell count in human immunodeficiency virus type 1-infected individuals

被引:30
作者
Derdeyn, CA
Costello, C
Kilby, JM
Sfakianos, G
Saag, MS
Kaslow, R
Bucy, RP
机构
[1] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35233 USA
[2] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35233 USA
[3] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35233 USA
关键词
D O I
10.1089/088922299310359
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Stromal cell-derived factor 1 (SDF-1) is the natural ligand that recognizes CXCR4, which also serves as a coreceptor for some strains of HIV-1, In this study, we explored SDF-1 blood levels among HIV-1-infected individuals exhibiting a wide range of CD4(+) cell counts, Plasma or serum concentrations of SDF-1 protein were measured by ELISA in samples from 31 HIV-1-seronegative individuals and 79 HIV-1-infected subjects, Although SDF-1 protein levels were stable for months among seronegative individuals (mean intrasubject variation, 17%), the absolute values varied widely (0.28 to 106.5 ng/ml; mean, 25.6 ng/ml), In HIV-1-infected subjects, there was a direct correlation between SDF-1 level and CD4(+) cell count. Subjects with fewer than 50 CD4(+) cells per cubic microliter of blood had significantly lower mean SDF-1 levels (+/-SD) than did either HIV-1-infected subjects with higher CD4(+) cell counts or uninfected controls: CD4(+) cell count <50, mean SDF-1 level of 10.7 +/- 33.7, 50 < CD4(+) cell count <200, mean SDF-1 level of 12.9 +/- 19.0, 200 < CD4(+) cell count <500, mean SDF-1 level of 19.3 +/- 36.8; CD4(+) cell count >500, mean SDF-1 level of 18.5 +/- 25.2; uninfected control mean SDF-1 level, 25.6 +/- 34.7. No significant change in SDF-1 level was detected after administration of antiretroviral therapy in nine subjects with advanced disease (mean intrasubject variation, 43%), Analysis of SDF-1 mRNA expression in lymph nodes from HIV-1-infected subjects at different disease stages revealed that the medullary cords contained stromal cells that express SDF-1 mRNA, This preliminary analysis suggests a possible link between lower SDF-1 levels and disease progression.
引用
收藏
页码:1063 / 1071
页数:9
相关论文
共 72 条
  • [41] The role of CCR5 and CCR2 polymorphisms in HTV-1 transmission and disease progression
    Michael, NL
    Louie, LG
    Rohrbaugh, AL
    Schultz, KA
    Dayhoff, DE
    Wang, CE
    Sheppard, HW
    [J]. NATURE MEDICINE, 1997, 3 (10) : 1160 - 1162
  • [42] CHANGING VIRUS-HOST INTERACTIONS IN THE COURSE OF HIV-1 INFECTION
    MIEDEMA, F
    MEYAARD, L
    KOOT, M
    KLEIN, MR
    ROOS, MTL
    GROENINK, M
    FOUCHIER, RAM
    VANTWOUT, AB
    TERSMETTE, M
    SCHELLEKENS, PTA
    SCHUITEMAKER, H
    [J]. IMMUNOLOGICAL REVIEWS, 1994, 140 : 35 - 72
  • [43] Genetic polymorphism of CCR5 gene and HIV disease:: the heterozygous (CCR5/Δccr5) genotype is neither essential nor sufficient for protection against disease progression
    Morawetz, RA
    Rizzardi, GP
    Glauser, D
    Rutschmann, O
    Hirschel, B
    Perrin, L
    Opravil, M
    Flepp, M
    von Overbeck, J
    Glauser, MP
    Ghezzi, S
    Vicenzi, E
    Poli, G
    Lazzarin, A
    Pantaleo, G
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) : 3223 - 3227
  • [44] The human CC chemokine receptor 5 (CCR5) gene -: Multiple transcripts with 5′-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons
    Mummidi, S
    Ahuja, SS
    McDaniel, BL
    Ahuja, SK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) : 30662 - 30671
  • [45] Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression
    Mummidi, S
    Ahuja, SS
    Gonzalez, E
    Anderson, SA
    Santiago, EN
    Stephan, KT
    Craig, FE
    O'Connell, P
    Tryon, V
    Clark, RA
    Dolan, MJ
    Ahuja, SK
    [J]. NATURE MEDICINE, 1998, 4 (07) : 786 - 793
  • [46] The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
    Oberlin, E
    Amara, A
    Bachelerie, F
    Bessia, C
    Virelizier, JL
    ArenzanaSeisdedos, F
    Schwartz, O
    Heard, JM
    ClarkLewis, I
    Legler, DF
    Loetscher, M
    Baggiolini, M
    Moser, B
    [J]. NATURE, 1996, 382 (6594) : 833 - 835
  • [47] Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS
    OBrien, WA
    Hartigan, PM
    Martin, D
    Esinhart, J
    Hill, A
    Benoit, S
    Rubin, M
    Lahart, C
    Wray, N
    Finegold, SM
    George, WL
    Dickinson, GM
    Klimas, N
    Diamond, G
    ZollaPazner, SB
    Jensen, PC
    Hawkes, C
    Oster, C
    Gordin, F
    Labriola, AM
    Spivey, P
    Matthews, T
    Weinhold, K
    Drusano, G
    Egorin, MJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (07) : 426 - 431
  • [48] Effect of immune activation on the dynamics of human immunodeficiency virus replication and on the distribution of viral quasispecies
    Ostrowski, MA
    Krakauer, DC
    Li, YX
    Justement, SJ
    Learn, G
    Ehler, LA
    Stanley, SK
    Nowak, M
    Fauci, AS
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (10) : 7772 - 7784
  • [49] PANOSKALTSISMORTARI A, 1995, BIOTECHNIQUES, V18, P300
  • [50] LYMPHOID ORGANS FUNCTION AS MAJOR RESERVOIRS FOR HUMAN-IMMUNODEFICIENCY-VIRUS
    PANTALEO, G
    GRAZIOSI, C
    BUTINI, L
    PIZZO, PA
    SCHNITTMAN, SM
    KOTLER, DP
    FAUCI, AS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (21) : 9838 - 9842